Capital Cardiology Associates Utilizes Cleerly for Advanced Heart Disease Analysis
Cleerly is a cutting-edge digital healthcare company leveraging artificial intelligence (AI) to analyze coronary computed tomography angiography (CCTA) images. This technology provides physicians with detailed insights into plaque buildup, arterial narrowing (stenosis), and reduced blood flow (ischemia), allowing for a more personalized approach to diagnosing and treating heart disease.
How Cleerly Enhances Cardiac Care:
AI-Powered Imaging Analysis
Cleerly’s AI algorithms assess CCTA scans, generating 3D images of the heart and coronary arteries for precise evaluation.Comprehensive Plaque Assessment
The software identifies and quantifies different types of plaque, offering a clearer picture of coronary artery disease (CAD) progression.Detection of Stenosis and Ischemia
Cleerly detects arterial narrowing and assesses the likelihood of ischemia, helping physicians address potential risks before complications arise.Personalized Treatment Plans
Detailed reports empower physicians to tailor treatment strategies, including lifestyle modifications and medical interventions, based on a patient’s unique condition.Tracking Disease Progression
Physicians can monitor changes in plaque buildup over time, refining treatment approaches as needed.Patient Education and Engagement
Cleerly provides easy-to-understand resources, enhancing patient awareness and involvement in their heart health journey.
By integrating Cleerly’s AI-driven technology, Capital Cardiology Associates enhances its ability to deliver precise, proactive, and personalized cardiovascular care.
